Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Jiang, Canhua ^a,b   Ye, Dongxia ^a   Qiu, Weiliu ^a   Zhang, Xiuli ^a   Zhang, Zhiyuan ^a   He, Di ^a   Zhang, Ping ^a   Chen, Wantao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ASTRAGALUS EXTRACT; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHINESE DRUG; CODONOPSIS EXTRACT; CYTOKINE; DRINKING WATER; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; GAMMA INTERFERON; GLOSSY PRIVET EXTRACT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SENTICOSIDE; SHENYANG; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; SHENYANG PRESCRIPTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CARCINOGENESIS; CD4 CD8 RATIO; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOCOMPETENCE; IMMUNOPATHOLOGY; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; SQUAMOUS CELL CARCINOMA; TH1 CELL; TH2 CELL; TONGUE CARCINOMA; TUMOR IMMUNITY; ANIMAL; CELL COUNT; CHEMICALLY INDUCED DISORDER; CHINESE MEDICINE; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; HELPER CELL; IMMUNOLOGY; METHODOLOGY; T LYMPHOCYTE SUBPOPULATION; TONGUE TUMOR;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CYTOKINES; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; MALE; MEDICINE, CHINESE TRADITIONAL; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TONGUE NEOPLASMS;

EID: 33947401426     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-40     Document Type: Article

References (36)

1. Lippman SM Sudbo J Hong WK Oral cancer prevention and the evolution of molecular-targeted drug development J Clin Oncol 2005 23 346-356 10.1200/ JCO.2005.09.128 15637397
2. Qiu WL Progress and achievements in diagnosis, treatment and research of oral and maxillofacial tumors: 10-year review Chinese Arch Otolaryngol Head Neck Surg 1996 3 57-61 (In Chinese)
3. van Dongen GA Snow GB Prospects for future studies in head and neck cancer Eur J Surg Oncol 1997 23 486-491 10.1016/S0748-7983(97)92789-X 9484916
4. Hawkins BL Heniford BW Ackermann DM Leonberger M Martinez SA Hendler FJ 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma Head Neck 1994 16 424-432 10.1002/hed.2880160506 7960739
5. Nagao M Sugimura T Molecular biology of the carcinogen, 4-nitroquinoline 1-oxide Adv Cancer Res 1976 23 131-169 818888
6. Daubersies P Galiegue-Zouitina S Koffel-Schwartz N Fuchs RP Loucheux-Lefebvre MH Bailleul B Mutation spectra of the two guanine adducts of the carcinogen 4-nitroquinoline 1-oxide in Escherichia coli. Influence of neighbouring base sequence on mutagenesis Carcinogenesis 1992 13 349-354 10.1093/carcin/13.3.349 1547523
7. Qiu W Lu C Guo Y Lin G Cao Y Guralnick W Hsich CC Albert T Wood W Everts E A prospective study on the Chinese prescription "Shenyang" in extending survival period of patient with oral squamous cell carcinoma Chinese Arch Otolaryngol Head Neck Surg 1996 3 69-73
8. Ohne M Satoh T Yamada S Takai H Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water Oral Surg Oral Med Oral Pathol 1985 59 600-607 10.1016/ 0030-4220(85)90189-6 3925407
9. Liu X He R Chen W A rat model of tongue mucosa squamous cell carcinoma induced by oral administration of 4NQO in drinking water Zhonghua Kou Qiang Yi Xue Za Zhi 1999 34 354-356 (In Chinese) 11776878
10. Hagenaars M Ensink NG Jonges LE Chambers WH Eggermont AM van de Velde CJ Fleuren GJ Kuppen PJ Hagenaars M Ensink NG Jonges LE Chambers WH Eggermont AM van de Velde CJ Fleuren GJ Kuppen PJ The development of a bi-specific anti-CD161A × anti-tumor antibody for rat NK cell targeting Immunobiology 1999 200 31-48 10084694
11. Erard F Garcia-Sanz JA Moriggl R Wild MT Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets J Immunol 1999 162 209-214 9886388
12. Ribeiro DA Favero Salvadori DM da Silva RN Ribeiro Darros B Alencar Marques ME Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis Oral Oncol 2004 40 910-915 10.1016/ j.oraloncology.2004.04.010 15380169
13. Tang XH Knudsen B Bemis D Tickoo S Gudas LJ Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice Clin Cancer Res 2004 10 301-313 10.1158/1078-0432.CCR-0999-3 14734483
14. Kaplan I Hochstadt T Dayan D PCNA in palate and tongue mucosal dysplastic lesions induced by topically applied 4NQO in desalivated rat Med Oral 2002 7 336-343 12415217
15. Tatematsu M Katsuyama T Furihata C Fukushima S Shirai T Kato T Ito N Cellular differentiation and histogenesis of rat glandular stomach cancers Jpn J Cancer Res 1990 81 760-767 1697850
16. Wallenius K Lekholm U Oral cancer in rats induced by the water soluble carcinogen 4-nitroquinoline-N-oxide Odont Rev 1973 24 39-48
17. Eastham RJ Mason JM Jennings BR Belew PW Maguda TA T-cell rosette test in squamous cell carcinoma of the head and neck Arch Otolaryngol 1976 102 171-175 1083730
18. Bier J Nickisch U Platz H The doubtful relevance of non-specific immune reactivity in patients with squamous cell carcinoma of the head and neck region Cancer 1983 52 1165- 1172 10.1002/ 1097-0142(19831001)52:7<1165::AID-CNCR2820520707>3.0.CO;2-Z 6603897
19. Gannot G Buchner A Keisari Y Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice Oral Oncol 2004 40 287-297 10.1016/j.oraloncology.2003.08.008 14747060
20. Hung K Hayashi R Lafond-Walker A Lowenstein C Pardoll D Levitsky H The central role of CD4(+) T cells in the antitumor immune response J Exp Med 1998 188 2357-2368 10.1084/jem.188.12.2357 9858522
21. Nishimura T Iwakabe K Sekimoto M Ohmi Y Yahata T Nakui M Sato T Habu S Tashiro H Sato M Ohta A Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo J Exp Med 1999 190 617-627 10.1084/jem.190.5.617 10477547
22. van den Broek MF Kagi D Zinkernagel RM Hengartner H Perforin dependence of natural killer cell-mediated tumor control in vivo Eur J Immnol 1995 25 3514-3516 10.1002/eji.1830251246
23. Smyth MJ Thia KY Cretney E Kelly JM Snook MB Forbes CA Scalzo AA Perforin is a major contributor to NK cell control of tumor metastasis J Immunol 1999 162 6658-6662 10352283
24. Kuss I Hathaway B Ferris RL Gooding W Whiteside TL Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck Clin Cancer Res 2004 10 3755-3762 10.1158/1078-0432.CCR-04-0054 15173082
25. Watson GA Lopez DM Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses J Immunol 1995 155 3124- 3134 7673727
26. Chen Z Malhotra PS Thomas GR Ondrey FG Duffey DC Smith CW Enamorado I Yeh NT Kroog GS Rudy S McCullagh L Mousa S Quezado M Herscher LL Van Waes C Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Clin Cancer Res 1995 5 1369-1379
27. Kuninaka S Yano T Yokoyama H Fukuyama Y Terazaki Y Uehara T Kanematsu T Asoh H Ichinose Y Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells Cytokine 2000 12 8 -1 10.1006/ cyto.1998.0504 10623436
28. Liss C Fekete MJ Hasina R Lam CD Lingen MW Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages Int J Cancer 2001 93 781-785 10.1002/ijc.1407 11519037
29. Lathers DM Young MR Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck Cytokine 2004 25 220- 228 10.1016/j.cyto.2003.11.005 15036248
30. Huang DB Ran RZ Yu ZF Effect of Acanthopanax senticosus injection on the activities of human tumor necrosis factor and natural killer cell in blood in the patients with lung cancer Zhongguo Zhong Yao Za Zh 2005 30 621-624
31. Ha ES Hwang SH Shin KS Yu KW Lee KH Choi JS Park WM Yoon TJ Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation Arch Pharm Res 2004 27 217 224 15022725
32. Xie SS Immunoregulatory effect of polysaccharide of Acanthopanax senticosus (PAS). I. Immunological mechanism of PAS against cancer Zhonghua Zhong Liu Za Zhi 1989 11 338- 340 2620627
33. Agarwal A Rani M Saha GK Valarmathi TM Bahadur S Mohanti BK Das SN Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma Immunol Invest 2003 32 17 30 10.1081/ IMM-120019205 12722939
34. Nishimura T Nakui M Sato M Iwakabe K Kitamura H Sekimoto M Ohta A Koda T Nishimura S The critical role of Th1-dominant immunity in tumor immunology Cancer Chemother Pharmacol 2000 46 52-61 10.1007/PL00014051
35. Elsasser-Beile U Kolble N Grussenmeyer T Schultze-Seemann W Wetterauer U Gallati H Schulte Monting J von Kleist S Th1 and Th2 cytokine response patterns in leukocyte cultures of patients with urinary bladder, renal cell and prostate carcinomas Tumour Biol 1998 19 470-476 10.1159/ 000030039 9817975
36. van Sandick JW Boermeester MA Gisbertz SS ten Berge IJ Out TA van der Pouw Kraan TC van Lanschot JJ Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: Relation to pTNM stage and clinical outcome Cancer Immunol Immunother 2003 52 617-624 10.1007/s00262-003-0406-7 12802519